TScan Therapeutics, Inc. (NASDAQ:TCRX) Financings

TScan Therapeutics, Inc.

Financings

RaiseDate
Registered direct offering of pre-funded warrants
Announced: about US$30M · US$4 a share · Warrants at US$0.0001
Buyers: Lynx1 Capital Management LP (with an investment fund advised by Lynx1, buying approximately $30 million of pre-funded warrants)
Use of proceeds: Extend cash runway to fund operations into the first quarter of 2027
Dec 26, 2024

Read by 6ix AI from the company's releases